Video

Strategy for Overcoming Resistance to Immunotherapy Unleashes Power of Dendritic Cells

Immune checkpoint inhibitor therapy, which activates T cells to kill tumor cells, is an effective way to treat some cancer types.

Video

Is Your Patient Immunocompromised?

Director of the Transplant & Cellular Therapy Center at Roswell Park Comprehensive Cancer Center, Phillip McCarthy, MD, discusses protocols in place to ensure the safety of our most vulnerable patient population. Dr. McCarthy also reviews ...

Video

Managing Toxicities of Immunotherapy

Igor Puzanov, MD, MSCI, FACP, is an expert in the management of immunotherapy toxicities. In this video presentation, he shares vital information for physicians who care for patients undergoing immunotherapy treatment.

Video

Fundamentals of Cancer Immunotherapy

Gurkamal Chatta, MD, Clinical Chief of Genitourinary Medicine, presents on immuno-oncology, new immunotherapy cancer treatments and how the immune system responds to cancer.

News

Roswell Park Researchers Identify New Biomarker of Response to Checkpoint Inhibitors

A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI) shortly after patients with non-small cell lung cancer (NSCLC) initiate therapy.

News

Identifying Neurotoxicity Earlier in CAR T-Cell Therapy

At Roswell Park Comprehensive Cancer Center, Philip McCarthy, MD, Director of the Transplant and Cellular Therapy Center in the Department of Medicine, and a multidisciplinary team of colleagues recently undertook a study to understand ...

News

New Roswell Park Strategy for Overcoming Resistance to Immunotherapy Unleashes Power of Dendritic Cells

Many of the most aggressive and hard-to-treat cancers are highly effective at blocking T cells, known as the foot soldiers of the immune system, from reaching and responding to tumors. It’s a cancer defense mechanism that even groundbreaking ...